HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Predominant enhancement of apoptosis induced by methyl jasmonate in bladder cancer cells: therapeutic effect of the Antp-conjugated Smac peptide.

Abstract
Methyl jasmonate (MJ) has recently attracted attention as a promising antitumoral compound because of its highly specific proapoptotic properties in a wide range of malignancies. However, the high doses required to achieve a therapeutic benefit have limited its clinical development. Here, we hypothesize that the family of inhibitor of apoptosis proteins (IAPs) may inhibit MJ-mediated apoptosis in cancer cells. We combined MJ with the IAPs inhibitor, the second mitochondria-derived activator of caspases (Smac) peptide to treat bladder cancer cells. The results showed that the combination of MJ and Smac peptide enhanced the apoptosis-inducing effect in a synergistic manner by releasing and activating IAPs-bounding caspase-3. These findings suggest that the inhibition of IAPs could overcome the resistance of cancer cells to MJ.
AuthorsXing-yuan Xiao, Guo-song Jiang, Liang Wang, Lei Lv, Fu-Qing Zeng
JournalAnti-cancer drugs (Anticancer Drugs) Vol. 22 Issue 9 Pg. 853-63 (Oct 2011) ISSN: 1473-5741 [Electronic] England
PMID21642838 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Acetates
  • Antennapedia Homeodomain Protein
  • Antineoplastic Agents
  • Antp protein, Drosophila
  • BIRC5 protein, human
  • Cyclopentanes
  • Drosophila Proteins
  • Fluorescent Dyes
  • Inhibitor of Apoptosis Proteins
  • Oligopeptides
  • Oxylipins
  • SMAC peptide
  • Survivin
  • X-Linked Inhibitor of Apoptosis Protein
  • methyl jasmonate
  • Caspase 3
  • Caspase 9
  • Bisbenzimidazole
Topics
  • Acetates (pharmacology)
  • Antennapedia Homeodomain Protein
  • Antineoplastic Agents (metabolism, pharmacology)
  • Apoptosis (drug effects)
  • Bisbenzimidazole
  • Caspase 3 (metabolism)
  • Caspase 9 (metabolism)
  • Cell Survival (drug effects)
  • Cyclopentanes (pharmacology)
  • Drosophila Proteins
  • Drug Evaluation, Preclinical
  • Drug Synergism
  • Fluorescent Dyes
  • HEK293 Cells
  • Humans
  • Inhibitor of Apoptosis Proteins (metabolism)
  • Molecular Targeted Therapy
  • Oligopeptides (metabolism, pharmacology)
  • Oxylipins (pharmacology)
  • Survivin
  • Tumor Cells, Cultured
  • Urinary Bladder Neoplasms (drug therapy, metabolism)
  • X-Linked Inhibitor of Apoptosis Protein (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: